“

Roche could have six new active pharmaceutical ingredients approved within two years. We never had this before, given the latest developments it is not at all the case any more that everything has to succeed in terms of what lies ahead with the pipeline in the near term. If even a part succeeds we are on course for further sustainable sales growth.